LRP-5

LRP-5

LRP-5 詳細

Molecule Name
Low-density lipoprotein receptor-related protein 5
Drug Development Progress
治験薬の数2
市販薬剤の数0
研究&開発段階Phase 3 Clinical
ターゲットの別称
バックグランド
Low-density lipoprotein receptor-related protein 5(LRP-5) is also known as BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPTA1, VBCH2, LDL receptor related protein 5 and PCLD4. LRP5 is a transmembrane low-density lipoprotein receptor that shares a similar structure with LRP6. LRP5 acts as a co-receptor with LRP6 and the Frizzled protein family members for transducing signals by Wnt proteins through the canonical Wnt pathway. This protein plays a key role in skeletal homeostasis. Mutations in LRP5 can lead to considerable changes in bone mass. A loss-of-function mutation causes osteoporosis-pseudoglioma (decrease in bone mass), while a gain-of-function mutation causes drastic increases in bone mass.

LRP-5 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
RestoretEYE103; EYE-103; MK-3000; ANT-39Phase 3 ClinicalEyebiotech Ltd
Diabetic macular oedema; Macular Degeneration; Retinal Vein Occlusion
詳細
BI-905681BI-905681Phase 1 ClinicalBoehringer Ingelheim Ltd
Neoplasms
詳細